BGNE241220P150000
- 0.55
- 0.000.00%
BeiGene Newsroom
BeiGene to Rebrand as BeOne Medicines With Oncology-Focused New Nasdaq Ticker "ONC"
Express News | Beigene - Will Change Its Nasdaq Ticker Symbol for Its American Depositary Shares From "Bgne" to "Onc" on Jan 2, 2025
BEIGENE (688235.SH): Plans to change the company's Nasdaq stock code to "ONC".
Gelonghui, December 23rd ┃ BEIGENE (688235.SH) announced that the company's American depositary shares traded on Nasdaq will change their stock code from "BGNE" to "ONC," effective from January 2, 2025, to emphasize the company's firm commitment to providing innovative oncology drugs globally. The stock code and abbreviated name on the Shanghai Stock Exchange and the stock code and abbreviated name on the Hong Kong Stock Exchange will remain unchanged. The change of the Nasdaq stock code can be implemented without submission for discussion at the company’s shareholder meeting.
BeiGene to Change Nasdaq Ticker Symbol to "ONC" on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
Express News | Beigene to Change Nasdaq Ticker Symbol to “Onc” on January 2; Present at 43Rd Annual J.P. Morgan Healthcare Conference
BeiGene Gets FDA Orphan Designation in Waldenstrom Macroglobulinemia Treatment
Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $286
TD Cowen Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $260
BeiGene (BGNE) Gets a Buy From TD Cowen
JMP Securities Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $288
BeiGene: Promising Growth Trajectory and Investment Opportunity Backed by Strong Product Pipeline and Robust Financials
Express News | JPMorgan Chase & Co's Short Position in Shares of Beigene Decreases to 1.66% on Dec. 11 From 2.42% - HKEX
BEIGENE issued 1.3 million shares due to the exercise of stock options.
BEIGENE (06160) announced that 1.3 million shares will be issued due to a Director exercising stock options on December 14, 2024.
Selected announcements | Ping An Insurance's original premium income in the current year is nearly 800 billion yuan; GANFENGLITHIUM's Goulamina spodumene project phase one has officially gone into production.
In the first 11 months, New China Life Insurance accumulated original insurance premium income of 163.1663 billion yuan, a year-on-year increase of 2.2%; Ideal Autos granted a total of 3.94697 million restricted stock units.
BEIGENE (06160.HK) issued 1.3 million shares due to the exercise of stock options.
Gelonghui reported on December 16 that BEIGENE (06160.HK) announced the issuance of 1.3 million ordinary shares due to a Director exercising stock options on December 14, 2024.
Super Micro Computer, Adobe And Nucor Are Among Top Large Cap Losers Last Week (December 9-13): Are The Others In Your Portfolio?
Sector Update: Health Care Stocks Steady Premarket Friday
Sector Update: Health Care
CSPC Pharmaceutical Group Grants Exclusive License of Cancer Inhibitor to BeiGene Switzerland
Express News | JPMorgan Chase & Co's Long Position in Shares of Beigene Increases to 10.94% on Dec 9 From 9.92% - HKEX